Skip to main content

We are delighted to introduce Monika Yanovska as the newest member of the 3R-Center for In Vitro Models and Alternatives to Animal Testing She joined our team as a scientific researcher on October 15, 2024, and will be supporting the Core Facility für Microphysiological Systems (MPS). With her extensive expertise in microphysiological systems, international research experience, and passion for introducing scientists to the potential of innovative, human-relevant in vitro test systems, she is a valuable addition to our team. We look forward to her contributions in establishing the MPS Core Facility in Tübingen.

Monika Yanovska obtained her Bachelor’s degree in Biomedical Sciences from Maastricht University (Netherlands). In her bachelor’s thesis, conducted in the research group of Prof. Pilar Martinez at the School of Mental Health and Neuroscience, she evaluated the efficiency of adeno-associated virus-mediated expression of ceramide transport protein (long isoform) in the brains of wild-type mice. She then continued working as a researcher, focusing on the effects of a sphingosine-1-phosphate analog on amyloid-β pathology and neuroinflammation in an Alzheimer’s disease mouse model.

She completed her Master’s degree in Biomedical Sciences at Leiden University (Netherlands). In the first year of her studies, she worked under the supervision of Dr. Araci Rondon in the group of Prof. Henri Versteeg at the Department of Internal Medicine (Leiden University), developing an Organ-on-a-Chip model to study the interaction between cancer and thrombosis. She then conducted her master’s thesis at the KTH Royal Institute of Technology and Karolinska Institute (Sweden) in the group of Prof. Anna Herland, where she gained insights into the differentiation and characterization of vascular cells derived from hiPSCs of patients with glucose haploinsufficiency, under the supervision of Dr. Julia Rogal.

After completing her studies, she worked as a research engineer in the group of Prof. A. Herland, developing an innovative human Neurovascular-Unit-on-a-Chip model using human induced pluripotent stem cells (hiPSCs) to study metabolic activity in the neurovasculature and brain vasculature formation.

Now, at the Core Facility for Microphysiological Systems, Monika Yanovska will be involved in project planning, conducting both theoretical and practical training, and supporting scientists in the implementation of microphysiological systems in their research.

Welcome to the team, Monika Yanovska!